Phase Forward Enhances Clinical Adverse Event Reporting And Regulatory Compliance; Clintrace 4.1 Features Reporting Capabilities Achieved Through Integration With Cognos ReportNet, Compliance With FDA MedWatch 3500A Guidelines

WALTHAM, Mass.--(BUSINESS WIRE)--Sept. 5, 2006--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the immediate availability of a new version (4.1) of the Clintrace(TM) adverse event tracking and reporting system. A comprehensive solution for safety data collection, management and submission, Clintrace 4.1 features reporting capabilities that are the result of tight integration with Cognos, Inc.'s ReportNet product. The Clintrace Reporting Workspace (the integration with ReportNet) will provide additional reporting on adverse event and operational information with enhanced data analysis capabilities.